Movement Alert|Intel Rises 3.7% in Pre-Market Trading, $20 Billion Stock Offering Massively Oversubscribed with 33% of Orders Unfilled

Market Focus
Aug 12

On August 12, Intel rose 3.7% in pre-market trading, trading at approximately $101.33 per share, with turnover of $2.74 billion. The rally follows confirmation that Intel's upsized $20 billion stock offering was completed with overwhelming demand, signaling a sharp reversal from the dilution-driven selloff earlier in the week.

Intel priced approximately 210.5 million shares at $95 each, with total subscription demand reportedly exceeding $100 billion. Approximately 33% of investor orders did not receive allocation due to the massive oversubscription. The offering was originally planned at $15 billion but was upsized to $20 billion given the strength of institutional appetite. Investor Dan Niles suggested the large-scale capital raise may indicate Intel is close to signing a major foundry customer.

The successful placement effectively shifted market focus from equity dilution concerns — which had driven the stock down over 5% on August 10 — toward the demand signal embedded in the oversubscription. UBS adjusted its Intel price target to $112 from $121 while maintaining a Neutral rating; the analyst consensus mean target remains at $121.24 with an average Overweight rating.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10